Us Nuclear Corp. (UCLE) intrinsic value & 10-year financials
Us Nuclear Corp. (UCLE) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue shrank 2.1% a year to $2.2M, with an average return on invested capital of -532.3%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.02
- Market cap
- $1.1M
- Revenue (FY2024)
- $2.2M
- Revenue growth (10-yr CAGR)
- -2.1%
- ROIC (10-yr avg)
- -532.3%
- Free cash flow (FY2024)
- —
UCLE 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2024 | $2.2M | -$1.7M | -$0.04 | — | -70.1% | 334.3% |
| FY2023 | $2.2M | -$3.4M | -$0.10 | -$264.3K | -73.6% | 219.4% |
| FY2022 | $2.1M | -$2.0M | -$0.03 | — | -71.5% | -4394.8% |
| FY2021 | $2.1M | -$1.9M | -$0.07 | -$447.5K | -63.7% | -291.3% |
| FY2020 | $1.8M | -$3.5M | — | — | -118.9% | -530.0% |
| FY2019 | $3.5M | -$3.2M | — | -$134.2K | -69.5% | -361.9% |
| FY2018 | $3.6M | -$2.4M | — | -$400.6K | -65.8% | -238.6% |
| FY2017 | $3.1M | $10.1K | — | $162.4K | 1.1% | 3.7% |
| FY2016 | $2.1M | -$1.6M | — | -$285.1K | -75.6% | -79.1% |
| FY2015 | $2.7M | $399.4K | — | — | 16.0% | 15.5% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
US NUCLEAR CORP. is facing top-line stagnation, with revenue contracting over the decade.
US NUCLEAR CORP. has historically struggled to out-earn its cost of capital, averaging just -11.2% ROIC.
US NUCLEAR CORP. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, US NUCLEAR CORP. is modeled at -2.1% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-0.15 per share.